Skip to main content

Table 3 Patient characteristics and prevalence of comorbidities in HAM-net-registered patients

From: Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan

 

All the HAM-net-registered patients

(n = 486)

Sex: Female

363 (74.7%)

Age at baseline (year)a

62.0 ± 10.7

Age at onset (year)a

44.8 ± 14.9

Disease durationa (time from onset to the baseline)

16.1 ± 11.3

Baseline OMDSa

5.7 ± 2.3

Rapid progressorsb

96 (19.8%)

Comorbidities

Prevalence

Uveitis

37 (7.6%)

Sjogren’s syndrome

18 (3.7%)

Rheumatoid arthritis

13 (2.7%)

Bone Fracture

12 (2.5%)

 Lower limb fracture

5 (1.0%)

 Compression fracture

5 (1.0%)

 Upper limb fracture

0 (0.0%)

Herpes zoster

5 (1.0%)

Interstitial pneumonia

4 (0.8%)

Tuberculosis

0 (0.0%)

Diabetes mellitusc

28 (5.8%)

Cataractc

27 (5.6%)

Glaucomac

12 (2.5%)

  1. aData are expressed as mean ± standard deviation
  2. bRapid progressors were defined as those who developed OMDS 5 or above within 2 years from the onset of motor symptoms
  3. cThese data are based on open-ended questions about comorbidities, Abbreviation: OMDS, Osame motor disability score